RESEARCH DRIVES US
Clinical research is just one part of the process that brings a new therapy from the laboratory to the patients. We believe that this stage of discovery is the foundation for all advancements in healthcare.
What is Clinical Research?
In order for clinical trials to take place for a new therapy or drug, drug developers must submit an application to the FDA. The drug developer must show that the new therapy or drug has demonstrated, during the pre-clinical research stage, that it’s likely to enhance patient care. The clinical trials may begin if the FDA approves it. The Clinical Research Division of Regeneris Medical are proud to be a part of this important process by conducting clinical trials for a number of cellular therapies being developed by various drug developers.
Ready to Get Started?
Discoveries in recent years have suggested that these cells have the ability to differentiate into a variety of cell types including bone cells, cartilage, and connective tissues, but they also have tremendous cellular activity and release potent growth factors. This phenomenon is referred to as stem cell transdifferentiation or plasticity. Under investigational protocols, these cells can be deployed to treat a number of degenerative conditions and diseases.